Novo Nordisk
NVO
933 hedge funds and large institutions have $16.3B invested in Novo Nordisk in 2022 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 323 increasing their positions, 313 reducing their positions, and 51 closing their positions.
78% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 51
70% more funds holding in top 10
Funds holding in top 10: 23 → 39 (+16)
13% more call options, than puts
Call options by funds: $140M | Put options by funds: $124M
7% more capital invested
Capital invested by funds: $15.2B → $16.3B (+$1.08B)
3% more funds holding
Funds holding: 902 → 933 (+31)
1.4% more ownership
Funds ownership: 15.56% → 16.96% (+1.4%)
3% more repeat investments, than reductions
Existing positions increased: 323 | Existing positions reduced: 313
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$554M |
| 2 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
+$407M |
| 3 |
Morgan Stanley
New York
|
+$310M |
| 4 |
Millennium Management
New York
|
+$122M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$111M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
-$177M |
| 2 |
BlackRock
New York
|
-$170M |
| 3 |
Renaissance Technologies
New York
|
-$94.8M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$65.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$62M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FFA
976
Freedman Financial Associates
Peabody,
Massachusetts
| – | -$14K | -250 | Closed |
|
|
GAM
977
Gemmer Asset Management
Walnut Creek,
California
| – | -$11K | -202 | Closed |
|
|
HI
978
Hoey Investments
Coatesville,
Pennsylvania
| – | -$7K | -126 | Closed |
|
|
ODG
979
O'Dell Group
Cincinnati,
Ohio
| – | -$7K | -124 | Closed |
|
980
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
| – | -$5K | -90 | Closed |
|
|
BDWM
981
Brewin Dolphin Wealth Management
Conskleagh, Dublin,
Ireland
| – | -$4K | -64 | Closed |
|
|
CS
982
Candriam SCA
Strassen, Luxembourg,
Luxembourg
| – | -$2K | -42 | Closed |
|
|
GEA
983
Glen Eagle Advisors
Kingston,
New Jersey
| – | -$1.44K | -26 | Closed |
|
|
SOW
984
State of Wyoming
Cheyenne,
Wyoming
| – | -$1K | -20 | Closed |
|
NVO Hedge Fund Activity: Q2 2022 in Review
933 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2022, worth a combined $16.3B — up 7.1% from $15.2B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new NVO positions and 51 closed out — a net gain of 40 holders — while 323 added to existing stakes and 313 trimmed.
The largest buyer was Jennison Associates, adding an estimated $554M. The largest seller was Fisher Asset Management, cutting an estimated $177M.
- 933 institutional investors held Novo Nordisk (NVO) as of Q2 2022, up from 902 in Q1 2022.
- Funds reported $16.3B of Novo Nordisk stock for Q2 2022, up 7.1% quarter-over-quarter.
- 91 funds opened new Novo Nordisk positions in Q2 2022 and 51 closed out, a net change of +40 holders.
- The largest Novo Nordisk buyer in Q2 2022 was Jennison Associates, an estimated $554M added.
- The largest Novo Nordisk seller in Q2 2022 was Fisher Asset Management, an estimated $177M sold.
Based on aggregated 13F filings for Q2 2022.